ConductScience.org, home

Paper77050

Effects of alpha2-plasmin inhibitor on fibrin clot lysis. Its comparison with alpha2-macroglobulin.

Aoki N and 2 others. Thromb Haemost, 1978. Cited by 86 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Effects of alpha2-plasmin inhibitor on fibrin clot lysis. Its comparison with alpha2-macroglobulin. Papers, record 77050. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/77050

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Effects of alpha2-plasmin inhibitor on fibrin clot lysis. Its comparison with alpha2-macroglobulin.
PubMed
Journal
Thromb Haemost
PubMed
Year
1978
PubMed
Publication types
Comparative Study, Journal Article
PubMed
Citations, by iCite
86
iCite
Relative citation ratio, by iCite
2.97
iCite
Revised in PubMed
2013-11-21
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Aoki NN
2Moroi MM
3Tachiya KK

Source PubMed

Topics7

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antifibrinolytic AgentsMajor topic
FibrinolysisMajor topic
Aminocaproic Acid
Humans
Plasminogen
Urokinase-Type Plasminogen Activator
alpha-Macroglobulins

Source PubMed

Cited by16

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 86 citations.

PMIDTitleJournalYearIn PapersSource
36,452,200Plasmin Inhibitor in Health and Diabetes: Role of the Protein as a Therapeutic Target.TH Open2022https://conductscience.org/library/papers/36452200PubMed
31,249,945Effects of Plasmin on von Willebrand Factor and Platelets: A Narrative Review.TH Open2018https://conductscience.org/library/papers/31249945PubMed
23,118,509Bacterial plasminogen receptors utilize host plasminogen system for effective invasion and dissemination.J Biomed Biotechnol2012https://conductscience.org/library/papers/23118509PubMed
18,564,219Evidence that alpha2-antiplasmin becomes covalently ligated to plasma fibrinogen in the circulation: a new role for plasma factor XIII in fibrinolysis regulation.J Thromb Haemost2008https://conductscience.org/library/papers/18564219PubMed
7,199,538Significance of cross-linking of alpha 2-plasmin inhibitor to fibrin in inhibition of fibrinolysis and in hemostasis.J Clin Invest1982https://conductscience.org/library/papers/7199538PubMed
6,459,779Secondary-site binding of Glu-plasmin, Lys-plasmin and miniplasmin to fibrin.Biochem J1981https://conductscience.org/library/papers/6459779PubMed
6,444,305Cross-linking of alpha 2-plasmin inhibitor to fibrin by fibrin-stabilizing factor.J Clin Invest1980https://conductscience.org/library/papers/6444305PubMed
6,178,757Catabolic pathways for streptokinase, plasmin, and streptokinase activator complex in mice. In vivo reaction of plasminogen activator with alpha 2-macroglobulin.J Clin Invest1982https://conductscience.org/library/papers/6178757PubMed
6,166,634Alpha2-plasmin inhibitor and alpha2-macroglobulin-plasmin complexes in plasma. Quantitation by an enzyme-linked differential antibody immunosorbent assay.J Clin Invest1981https://conductscience.org/library/papers/6166634PubMed
3,166,140Organization of the human alpha 2-plasmin inhibitor gene.Proc Natl Acad Sci U S A1988https://conductscience.org/library/papers/3166140PubMed
3,100,038Streptokinase, urokinase, and tissue plasminogen activator: pharmacokinetics, relative advantages, and methods for maximizing rates and consistency of lysis.Cardiovasc Intervent Radiol1986https://conductscience.org/library/papers/3100038PubMed
3,088,041Localization of the binding site of tissue-type plasminogen activator to fibrin.J Clin Invest1986https://conductscience.org/library/papers/3088041PubMed
2,526,671Clinical disorders of fibrinolysis: a critical review.Blut1989https://conductscience.org/library/papers/2526671PubMed
1,708,234Soluble fibrin preparations inhibit the reaction of plasmin with alpha 2-macroglobulin. Comparison with alpha 2-antiplasmin and leupeptin.Biochem J1991https://conductscience.org/library/papers/1708234PubMed
156,364Inhibitory spectrum of alpha 2-plasmin inhibitor.Proc Natl Acad Sci U S A1979https://conductscience.org/library/papers/156364PubMed
156,196Congenital deficiency of alpha 2-plasmin inhibitor associated with severe hemorrhagic tendency.J Clin Invest1979https://conductscience.org/library/papers/156196PubMed

Genes4

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
A2M2PubTator's text mininghttps://conductscience.org/library/genes/2NCBI Gene
PLAU5,328PubTator's text mininghttps://conductscience.org/library/genes/5328NCBI Gene
PLG5,340PubTator's text mininghttps://conductscience.org/library/genes/5340NCBI Gene
SERPINF25,345PubTator's text mininghttps://conductscience.org/library/genes/5345NCBI Gene

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/77050

GET https://conductscience.org/api/papers/v1/77050/authors